{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:05:11Z","timestamp":1775840711324,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Breast Cancer Group"},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Governmental Funding of Clinical Research within National Health Services, Sweden"},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>High-performing imaging and predictive markers are warranted to minimize surgical overtreatment of the axilla in breast cancer (BC) patients receiving neoadjuvant chemotherapy (NACT). Here we have investigated whether axillary ultrasound (AUS) could identify axillary lymph node (ALN) metastasis (ALNM) pre-NACT and post-NACT for BC. The association of tumor, AUS features and mammographic density (MD) with axillary-pathological complete response (axillary-pCR) post-NACT was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The NeoDense-study cohort (<jats:italic>N<\/jats:italic>\u2009=\u2009202, NACT during 2014\u20132019), constituted a pre-NACT cohort, whereas patients whom had a cytology verified ALNM pre-NACT and an axillary dissection performed (<jats:italic>N<\/jats:italic>\u2009=\u2009114) defined a post-NACT cohort. AUS characteristics were prospectively collected pre- and post-NACT. The diagnostic accuracy of AUS was evaluated and stratified by histological subtype and body mass index (BMI). Predictors of axillary-pCR were analyzed, including MD, using simple and multivariable logistic regression models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>AUS demonstrated superior performance for prediction of ALNM pre-NACT in comparison to post-NACT, as reflected by the positive predictive value (PPV) 0.94 (95% CI 0.89\u20130.97) and PPV 0.76 (95% CI 0.62\u20130.87), respectively. We found no difference in AUS performance according to neither BMI nor histological subtype. Independent predictors of axillary-pCR were: premenopausal status, ER-negativity, HER2-overexpression, and high MD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Baseline AUS could, to a large extent, identify ALNM; however, post-NACT, AUS was insufficient to determine remaining ALNM. Thus, our results support the surgical staging of the axilla post-NACT. Baseline tumor biomarkers and patient characteristics were predictive of axillary-pCR. Larger, multicenter studies are needed to evaluate the performance of AUS post-NACT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10549-021-06283-8","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:02:46Z","timestamp":1623524566000},"page":"131-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1265-8649","authenticated-orcid":false,"given":"Ida","family":"Skarping","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-7624","authenticated-orcid":false,"given":"Daniel","family":"F\u00f6rnvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-3882","authenticated-orcid":false,"given":"Sophia","family":"Zackrisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-8893","authenticated-orcid":false,"given":"Signe","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-3130","authenticated-orcid":false,"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"10","key":"6283_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","volume":"30","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M et al (2019) Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol 30(10):1541\u20131557","journal-title":"Ann Oncol"},{"issue":"15","key":"6283_CR2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30(15):1796\u20131804","journal-title":"J Clin Oncol"},{"issue":"9938","key":"6283_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384(9938):164\u2013172","journal-title":"Lancet"},{"issue":"7","key":"6283_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609\u2013618","journal-title":"Lancet Oncol"},{"issue":"14","key":"6283_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455\u20131461","journal-title":"JAMA"},{"issue":"1052","key":"6283_CR6","doi-asserted-by":"publisher","first-page":"20150143","DOI":"10.1259\/bjr.20150143","volume":"88","author":"S You","year":"2015","unstructured":"You S, Kang DK, Jung YS, An YS, Jeon GS, Kim TH (2015) Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (1)(8)F-FDG PET\/CT. Br J Radiol 88(1052):20150143","journal-title":"Br J Radiol"},{"issue":"3","key":"6283_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","volume":"269","author":"JM Simons","year":"2019","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML (2019) Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg 269(3):432\u2013442","journal-title":"Ann Surg"},{"issue":"30","key":"6283_CR8","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","volume":"33","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT (2015) Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol 33(30):3386\u20133393","journal-title":"J Clin Oncol"},{"issue":"11S","key":"6283_CR9","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1016\/j.jacr.2017.08.037","volume":"14","author":"PJ Slanetz","year":"2017","unstructured":"Expert Panel on Breast I, Slanetz PJ, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA et al (2017) ACR appropriateness criteria((R)) monitoring response to neoadjuvant systemic therapy for breast cancer. J Am Coll Radiol 14(11S):S462\u2013S475","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"6283_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1148\/rg.336125060","volume":"33","author":"JS Ecanow","year":"2013","unstructured":"Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM (2013) Axillary staging of breast cancer: what the radiologist should know. Radiographics 33(6):1589\u20131612","journal-title":"Radiographics"},{"key":"6283_CR11","unstructured":"Br\u00f6stcancer -Nationellt v\u00e5rdprogram 2020, https:\/\/kunskapsbanken.cancercentrum.se\/globalassets\/cancerdiagnoser\/brost\/vardprogram\/nationellt-vardprogram-brostcancer.pdf. Accessed 30 Sept 2020"},{"issue":"3","key":"6283_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000489329","volume":"13","author":"C Liedtke","year":"2018","unstructured":"Liedtke C, Jackisch C, Thill M, Thomssen C, Muller V, Janni W, Committee AGOB (2018) AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2018. Breast Care (Basel) 13(3):196\u2013208","journal-title":"Breast Care (Basel)"},{"issue":"8","key":"6283_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E (2019) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 30(8):1194\u20131220","journal-title":"Ann Oncol"},{"issue":"5","key":"6283_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2214\/AJR.05.0936","volume":"186","author":"S Alvarez","year":"2006","unstructured":"Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol 186(5):1342\u20131348","journal-title":"Am J Roentgenol"},{"issue":"2","key":"6283_CR15","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1634\/theoncologist.2019-0427","volume":"25","author":"MA Marino","year":"2020","unstructured":"Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K (2020) Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools. Oncologist 25(2):e231\u2013e242","journal-title":"Oncologist"},{"key":"6283_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.breast.2016.11.012","volume":"31","author":"L Schwentner","year":"2017","unstructured":"Schwentner L, Helms G, Nekljudova V, Ataseven B, Bauerfeind I, Ditsch N, Fehm T, Fleige B, Hauschild M, Heil J et al (2017) Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy\u2014results from the multi-center SENTINA trial. Breast 31:202\u2013207","journal-title":"Breast"},{"issue":"4","key":"6283_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4048\/jbc.2017.20.4.378","volume":"20","author":"HS Kim","year":"2017","unstructured":"Kim HS, Shin MS, Kim CJ, Yoo SH, Yoo TK, Eom YH, Chae BJ, Song BJ (2017) Improved model for predicting axillary response to neoadjuvant chemotherapy in patients with clinically node-positive breast cancer. J Breast Cancer 20(4):378\u2013385","journal-title":"J Breast Cancer"},{"issue":"10","key":"6283_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/0284185117690421","volume":"58","author":"SM Ha","year":"2017","unstructured":"Ha SM, Cha JH, Kim HH, Shin HJ, Chae EY, Choi WJ (2017) Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer. Acta Radiol 58(10):1198\u20131205","journal-title":"Acta Radiol"},{"issue":"3","key":"6283_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 33(3):258\u2013264","journal-title":"J Clin Oncol"},{"issue":"8","key":"6283_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/bjs.10791","volume":"105","author":"E Morrow","year":"2018","unstructured":"Morrow E, Lannigan A, Doughty J, Litherland J, Mansell J, Stallard S, Mallon E, Romics L (2018) Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast. Br J Surg 105(8):987\u2013995","journal-title":"Br J Surg"},{"issue":"2","key":"6283_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/tbj.13635","volume":"26","author":"VS Upadhyaya","year":"2020","unstructured":"Upadhyaya VS, Lim GH, Chan EYK, Fook-Chong SMC, Leong LCH (2020) Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging. Breast J 26(2):162\u2013167","journal-title":"Breast J"},{"issue":"8","key":"6283_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3109\/0284186X.2016.1146826","volume":"55","author":"L Dihge","year":"2016","unstructured":"Dihge L, Grabau DA, Rasmussen RW, Bendahl PO, Ryden L (2016) The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology. Acta Oncol 55(8):976\u2013982","journal-title":"Acta Oncol"},{"issue":"1","key":"6283_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal LH, Vallon-Christersson J, Hakkinen J, Hegardt C, Grabau D, Winter C, Brueffer C, Tang MH, Reutersward C, Schulz R et al (2015) The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med 7(1):20","journal-title":"Genome Med"},{"key":"6283_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.breast.2020.05.013","volume":"53","author":"I Skarping","year":"2020","unstructured":"Skarping I, Fornvik D, Heide-Jorgensen U, Sartor H, Hall P, Zackrisson S, Borgquist S (2020) Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden. Breast 53:33\u201341","journal-title":"Breast"},{"key":"6283_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0284186X.2020.1830167","volume":"59","author":"I Skarping","year":"2020","unstructured":"Skarping I, Fornvik D, Heide-Jorgensen U, Ryden L, Zackrisson S, Borgquist S (2020) Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study. Acta Oncol 59:1\u201310","journal-title":"Acta Oncol"},{"issue":"7","key":"6283_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/annonc\/mdv161","volume":"26","author":"V Bossuyt","year":"2015","unstructured":"Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T et al (2015) Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol 26(7):1280\u20131291","journal-title":"Ann Oncol"},{"issue":"5","key":"6283_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cncr.10786","volume":"95","author":"S Krishnamurthy","year":"2002","unstructured":"Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK (2002) Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982\u2013988","journal-title":"Cancer"},{"issue":"2","key":"6283_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13244-014-0367-8","volume":"6","author":"V Dialani","year":"2015","unstructured":"Dialani V, James DF, Slanetz PJ (2015) A practical approach to imaging the axilla. Insights Imaging 6(2):217\u2013229","journal-title":"Insights Imaging"},{"issue":"9","key":"6283_CR29","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.ultrasmedbio.2014.02.019","volume":"40","author":"SH Park","year":"2014","unstructured":"Park SH, Jeong YM, Cho SH, Jung HK, Kim SJ, Ryu HS (2014) Imaging findings of variable axillary mass and axillary lymphadenopathy. Ultrasound Med Biol 40(9):1934\u20131948","journal-title":"Ultrasound Med Biol"},{"key":"6283_CR30","volume-title":"ACR BI-RADS\u00ae atlas, breast imaging reporting and data system","author":"E Sickles","year":"2013","unstructured":"Sickles E, D\u2019Orsi CJ, Bassett LW et al (2013) ACR BI-RADS\u00ae mammography. ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. American College of Radiology, Reston"},{"key":"6283_CR31","first-page":"342","volume-title":"Robust breast composition measurement\u2014VolparaTM","author":"R Highnam","year":"2010","unstructured":"Highnam R, Brady SM, Yaffe MJ, Karssemeijer N, Harvey J (2010) Robust breast composition measurement\u2014VolparaTM. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 342\u2013349"},{"issue":"11","key":"6283_CR32","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1245\/s10434-016-5277-1","volume":"23","author":"J Vila","year":"2016","unstructured":"Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF et al (2016) Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer. Ann Surg Oncol 23(11):3501\u20133509","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"6283_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.clbc.2013.12.015","volume":"14","author":"RJ Schipper","year":"2014","unstructured":"Schipper RJ, Moossdorff M, Nelemans PJ, Nieuwenhuijzen GA, de Vries B, Strobbe LJ, Roumen RM, van den Berkmortel F, Tjan-Heijnen VC, Beets-Tan RG et al (2014) A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer. Clin Breast Cancer 14(5):315\u2013322","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"6283_CR34","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1245\/s10434-017-5872-9","volume":"24","author":"BL Murphy","year":"2017","unstructured":"Murphy BL, Hoskin TL, Heins CDN, Habermann EB, Boughey JC (2017) Preoperative prediction of node-negative disease after neoadjuvant chemotherapy in patients presenting with node-negative or node-positive breast cancer. Ann Surg Oncol 24(9):2518\u20132525","journal-title":"Ann Surg Oncol"},{"key":"6283_CR35","doi-asserted-by":"publisher","first-page":"32585","DOI":"10.1038\/srep32585","volume":"6","author":"X Jin","year":"2016","unstructured":"Jin X, Jiang YZ, Chen S, Shao ZM, Di GH (2016) A nomogram for predicting the pathological response of axillary lymph node metastasis in breast cancer patients. Sci Rep 6:32585","journal-title":"Sci Rep"},{"issue":"5","key":"6283_CR36","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","volume":"25","author":"O Kantor","year":"2018","unstructured":"Kantor O, Sipsy LM, Yao K, James TA (2018) A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 25(5):1304\u20131311","journal-title":"Ann Surg Oncol"},{"issue":"43","key":"6283_CR37","doi-asserted-by":"publisher","first-page":"e1720","DOI":"10.1097\/MD.0000000000001720","volume":"94","author":"JY Kim","year":"2015","unstructured":"Kim JY, Park HS, Kim S, Ryu J, Park S, Kim SI (2015) Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Medicine (Baltimore) 94(43):e1720","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"6283_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.suronc.2018.02.003","volume":"27","author":"L Ouldamer","year":"2018","unstructured":"Ouldamer L, Chas M, Arbion F, Body G, Cirier J, Ballester M, Bendifallah S, Darai E (2018) Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer. Surg Oncol 27(2):158\u2013165","journal-title":"Surg Oncol"},{"issue":"1","key":"6283_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/RUQ.0000000000000277","volume":"33","author":"HY Choi","year":"2017","unstructured":"Choi HY, Park M, Seo M, Song E, Shin SY, Sohn YM (2017) Preoperative axillary lymph node evaluation in breast cancer: current issues and literature review. Ultrasound Q 33(1):6\u201314","journal-title":"Ultrasound Q"},{"issue":"3","key":"6283_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC (2018) Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). Am J Roentgenol 210(3):669\u2013676","journal-title":"Am J Roentgenol"},{"key":"6283_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1102\/1470-7330.2009.0017","volume":"9","author":"S Ganeshalingam","year":"2009","unstructured":"Ganeshalingam S, Koh DM (2009) Nodal staging. Cancer Imaging 9:104\u2013111","journal-title":"Cancer Imaging"},{"issue":"6","key":"6283_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","volume":"225","author":"JJ Weber","year":"2017","unstructured":"Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, Pilewskie M, Van Zee KJ, Morrow M, El-Tamer M (2017) MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer. J Am Coll Surg 225(6):740\u2013746","journal-title":"J Am Coll Surg"},{"issue":"10","key":"6283_CR43","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","volume":"20","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Boughey JC, Jones KN, Shah SS, Glazebrook KN (2013) Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol 20(10):3199\u20133204","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"6283_CR44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ultrasmedbio.2005.04.012","volume":"31","author":"F Giovagnorio","year":"2005","unstructured":"Giovagnorio F, Drudi FM, Fanelli G, Flecca D, Francioso A (2005) Fatty changes as a misleading factor in the evaluation with ultrasound of superficial lymph nodes. Ultrasound Med Biol 31(8):1017\u20131022","journal-title":"Ultrasound Med Biol"},{"issue":"10","key":"6283_CR45","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-014-3902-4","volume":"21","author":"AR Shah","year":"2014","unstructured":"Shah AR, Glazebrook KN, Boughey JC, Hoskin TL, Shah SS, Bergquist JR, Dupont SC, Hieken TJ (2014) Does BMI affect the accuracy of preoperative axillary ultrasound in breast cancer patients? Ann Surg Oncol 21(10):3278\u20133283","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6283_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","volume":"293","author":"R Kim","year":"2019","unstructured":"Kim R, Chang JM, Lee HB, Lee SH, Kim SY, Kim ES, Cho N, Moon WK (2019) Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer. Radiology 293(1):49\u201357","journal-title":"Radiology"},{"issue":"4","key":"6283_CR47","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton T, Hunt KK (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg 260(4):608\u2013614 (discussion 614-606)","journal-title":"Ann Surg"},{"issue":"3","key":"6283_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-014-2901-2","volume":"144","author":"CW Huo","year":"2014","unstructured":"Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, Thompson EW (2014) Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 144(3):479\u2013502","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6283_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13058-016-0701-9","volume":"18","author":"MJ Sherratt","year":"2016","unstructured":"Sherratt MJ, McConnell JC, Streuli CH (2016) Raised mammographic density: causative mechanisms and biological consequences. Breast Cancer Res 18(1):45","journal-title":"Breast Cancer Res"},{"issue":"2","key":"6283_CR50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1148\/radiol.2015150089","volume":"278","author":"MS Bae","year":"2016","unstructured":"Bae MS, Moon HG, Han W, Noh DY, Ryu HS, Park IA, Chang JM, Cho N, Moon WK (2016) Early stage triple-negative breast cancer: imaging and clinical-pathologic factors associated with recurrence. Radiology 278(2):356\u2013364","journal-title":"Radiology"},{"issue":"1","key":"6283_CR51","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1186\/s12885-019-6485-4","volume":"19","author":"I Skarping","year":"2019","unstructured":"Skarping I, Fornvik D, Sartor H, Heide-Jorgensen U, Zackrisson S, Borgquist S (2019) Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer. BMC Cancer 19(1):1272","journal-title":"BMC Cancer"},{"issue":"5","key":"6283_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.breast.2015.05.007","volume":"24","author":"S Elsamany","year":"2015","unstructured":"Elsamany S, Alzahrani A, Abozeed WN, Rasmy A, Farooq MU, Elbiomy MA, Rawah E, Alsaleh K, Abdel-Aziz NM (2015) Mammographic breast density: predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast 24(5):576\u2013581","journal-title":"Breast"},{"issue":"6","key":"6283_CR53","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/bcr3570","volume":"15","author":"KA Bertrand","year":"2013","unstructured":"Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz V, Visscher D, Norman A, Couch F, Shepherd J, Fan B et al (2013) Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15(6):R104","journal-title":"Breast Cancer Res"},{"issue":"4","key":"6283_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejso.2011.01.006","volume":"37","author":"RF van la Parra","year":"2011","unstructured":"van la Parra RF, Peer PG, Ernst MF, Bosscha K (2011) Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol 37(4):290\u2013299","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"6283_CR55","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12885-019-5823-x","volume":"19","author":"S Majid","year":"2019","unstructured":"Majid S, Ryden L, Manjer J (2019) Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases. BMC Cancer 19(1):626","journal-title":"BMC Cancer"},{"issue":"4","key":"6283_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.suronc.2012.06.006","volume":"21","author":"L Zhang","year":"2012","unstructured":"Zhang L, Liu C, Wang W, Xu X, Chen B (2012) Is optimal timing of sentinel lymph node biopsy before neoadjuvant chemotherapy in patients with breast cancer? A literature review. Surg Oncol 21(4):252\u2013256","journal-title":"Surg Oncol"},{"issue":"1","key":"6283_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10549-017-4163-2","volume":"163","author":"L Zetterlund","year":"2017","unstructured":"Zetterlund L, Celebioglu F, Axelsson R, de Boniface J, Frisell J (2017) Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer. Breast Cancer Res Treat 163(1):93\u2013101","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"6283_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102(2):111\u2013118","journal-title":"J Surg Oncol"},{"issue":"10","key":"6283_CR59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"2","key":"6283_CR60","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"9","key":"6283_CR61","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/diagnostics10090717","volume":"10","author":"JS Pyo","year":"2020","unstructured":"Pyo JS, Jung J, Lee SG, Kim NY, Kang DW (2020) Diagnostic accuracy of fine-needle aspiration cytology and core-needle biopsy in the assessment of the axillary lymph nodes in breast cancer\u2014a meta-analysis. Diagnostics (Basel) 10(9):717","journal-title":"Diagnostics (Basel)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06283-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T02:50:28Z","timestamp":1635216628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06283-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6283"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06283-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SZ has received speakers\u2019 fees and travel support from Siemens Healthcare AG, and consultancy fees from Collective Minds Radiology AB. SB has received speakers\u2019 fees from Pfizer, is a study-specific advisor Pfizer, and has received travel support from Roche. The other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee in Lund, Sweden (Official records number: 2014\/13, 2014\/521 and 2016\/521).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for publication was obtained from all participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}